Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2629-2635

  Verret, Wendy J ^a   Arinaitwe, Emmanuel ^b   Wanzira, Humphrey ^b   Bigira, Victor ^b   Kakuru, Abel ^b   Kamya, Moses ^c   Tappero, Jordan W ^d   Sandison, Taylor ^e   Dorsey, Grant ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; DIHYDROARTEMISININ PLUS PIPERAQUINE; DUOCOTECXIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD SMEAR; BODY HEIGHT; BODY WEIGHT; CHEMOPROPHYLAXIS; CHILD; CHILD CARE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALNUTRITION; NUTRITIONAL STATUS; PARASITE CLEARANCE; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; UGANDA;

ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA; MALNUTRITION; PARASITEMIA; QUINOLINES;

EID: 79956294759     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01727-10     Document Type: Article

References (32)

1. Arinaitwe, E., et al. 2009. Artemether-lumefantrine versus dihydroartemisinin- piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin. Infect. Dis. 49:1629-1637.
2. Barnes, K. I., et al. 2007. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Malar. J. 6:122.
3. Bassat, Q., et al. 2009. Dihydroartemisinin-piperaquine and artemetherlumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One 4:e7871.
4. Cunningham-Rundles, S., D. F. McNeeley, and A. Moon. 2005. Mechanisms of nutrient modulation of the immune response. J. Allergy Clin. Immunol. 115:1119-1129.
5. Deen, J. L., G. E. Walraven, and L. von Seidlein. 2002. Increased risk for malaria in chronically malnourished children under 5 years of age in rural Gambia. J. Trop. Pediatr. 48:78-83.
6. de Onis, M., C. Monteiro, J. Akre, and G. Glugston. 1993. The worldwide magnitude of protein-energy malnutrition: an overview from the WHO Global Database on Child Growth. Bull. World Health Organ. 71:703-712.
7. de Onis, M., A. W. Onyango, E. Borghi, C. Garza, and H. Yang. 2006. Comparison of the World Health Organization (WHO) Child Growth Standards and the National Center for Health Statistics/WHO international growth reference: implications for child health programmes. Public Health Nutr. 9:942-947. (Pubitemid 46211797)
8. Fehintola, F. A., et al. 2004. Cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in nigerian children: a controlled clinical trial. Clin. Drug Invest. 24:149-155.
9. Fillol, F., et al. 2009. Influence of wasting and stunting at the onset of the rainy season on subsequent malaria morbidity among rural preschool children in Senegal. Am. J. Trop. Med. Hyg. 80:202-208.
10. Fillol, F., et al. 2009. Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response. Malar. J. 8:116.
11. Friedman, J. F., et al. 2005. Malaria and nutritional status among pre-school children: results from cross-sectional surveys in western Kenya. Am. J. Trop. Med. Hyg. 73:698-704.
12. Genton, B., F. Al-Yaman, M. Ginny, J. Taraika, and M. P. Alpers. 1998. Relation of anthropometry to malaria morbidity and immunity in Papua New Guinean children. Am. J. Clin. Nutr. 68:734-741.
13. Greenhouse, B., et al. 2006. Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am. J. Trop. Med. Hyg. 75:836-842.
14. Huber, P. J. 1967. The behavior of maximum likelihood estimates under nonstandard conditions, p. 221-233. In L. M. Le Cam and J. Neyman (ed.), Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, vol. 1: statistics. University of California Press, Berkeley, CA.
15. Kamya, M. R., et al. 2007. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS 21:2059-2066. (Pubitemid 47462155)
16. Macro International, Inc. 2007. Uganda demographic and health survey 2006. Macro International, Inc., Calverton, MD. http://www.measuredhs.com/pubs/ pdf/FR194/FR194.pdf.
17. Mermin, J., et al. 2006. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 367: 1256-1261.
18. Mermin, J., et al. 2004. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364:1428-1434. (Pubitemid 39370718)
19. Muller, O., M. Garenne, B. Kouyate, and H. Becher. 2003. The association between protein-energy malnutrition, malaria morbidity and all-cause mortality in West African children. Trop. Med. Int. Health 8:507-511.
20. Muller, O., and M. Krawinkel. 2005. Malnutrition and health in developing countries. CMAJ 173:279-286. (Pubitemid 41097746)
21. Okello, P. E., et al. 2006. Variation in malaria transmission intensity in seven sites throughout Uganda. Am. J. Trop. Med. Hyg. 75:219-225.
22. Oshikoya, K. A., and I. O. Senbanjo. 2009. Pathophysiological changes that affect drug disposition in protein-energy malnourished children. Nutr. Metab. (Lond.) 6:50.
23. Price, R. N., et al. 2007. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Antimicrob. Agents Chemother. 51:4090-4097.
24. Ratcliff, A., et al. 2007. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369:757-765. (Pubitemid 46335820)
25. Schaible, U. E., and S. H. Kaufmann. 2007. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 4:e115.
26. Snounou, G., S. Viriyakosol, W. Jarra, S. Thaithong, and K. N. Brown. 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol. Biochem. Parasitol. 58:283-292.
27. Tarning, J., et al. 2008. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob. Agents Chemother. 52:1052-1061.
28. World Health Organization. 2010. Guidelines for the treatment of malaria, 2nd ed. World Health Organization, Geneva, Switzerland. http://whqlibdoc .who.int/publications/2010/9789241564106-eng.pdf.
29. World Health Organization. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland. http://apps.who.int .malaria/docs/TreatmentGuidelines2006.pdf.
30. World Health Organization. 2005. World health report. World Health Organization, Geneva, Switzerland. http://www.who.int/whr/2005/whr2005-en.pdf.
31. World Health Organization. 2009. World malaria report 2009. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2009/ 9789241563901-eng.pdf.
32. Yeka, A., et al. 2008. Artemether-lumefantrine versus dihydroartemisininpiperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One 3:e2390.